Find News

Filter articles

Showing 131 to 140 of 3607 results

BGI hit with $8m damages bill in patent dispute with Illumina

02-12-2021Muireann Bolger

Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.

Moderna exposed after losing COVID-19 vaccine patent decision

02-12-2021Muireann Bolger

Moderna has failed to reverse an unfavourable ruling related to its COVID-19 vaccine technology, after the US Court of Appeals for the Federal Circuit upheld the validity of a patent owned by Arbutus Biopharma.

Fed Circuit split decision denies Biogen’s bid to revive MS drug patent


The US Court of Appeals for the Federal Circuit has refused Biogen’s attempt to revive a key patent for its multiple sclerosis drug Tecfidera (dimethyl fumarate), leaving Mylan’s successful challenge intact. 

Biofrontera settles patent dispute with Dusa over skin treatment

US30-11-2021Muireann Bolger

A US subsidiary of German skin treatment company Biofrontera has resolved its dispute with Dusa Pharmaceuticals, on the eve of a trial over patents covering a light therapy used to treat skin conditions, called BLU-U.

Fed Circ says Indivior patent was anticipated

US30-11-2021Alex Baldwin

The US Court of Appeals for the Federal Circuit has affirmed a US Patent Trial and Appeal Board decision that held that claims of a patent for dissolvable films containing therapeutic agents were anticipated.

Omicron variant delays COVID-19 IP waiver debate


The World Trade Organization has postponed its ministerial conference indefinitely, potentially ending the opportunity for countries to agree an IP waiver for COVID-19 vaccines this year.

Court denies Sun Pharma’s bid to avoid trial

India, US25-11-2021

Sun Pharma’s bid to avoid facing a trial over allegations of antitrust behaviour by an Indian drugmaker it acquired has been denied by a Massachusetts court.

Fed Circ invaded jury’s role in Repatha case, says Amgen

US25-11-2021Muireann Bolger

Amgen has urged the US Supreme Court to wade into its legal wrangle with Sanofi and Regeneron Pharmaceuticals over patents covering a cholesterol drug, Repatha.

Pfizer claims employee stole COVID-19 vaccine documents


Pfizer is currently investigating a soon-to-be former employee who it believes has transferred more than 12,000 files, many of which contain confidential and trade secret information, to her personal devices and has repeatedly attempted to cover her tracks.

BioMarin accuses engineer of stealing 1,800 files

US23-11-2021Muireann Bolger

BioMarin Pharmaceuticals has accused a former engineer who went to work for competitor Sangamo Therapeutics of stealing more than 1,800 files containing confidential information and trade secrets.

Showing 131 to 140 of 3607 results